Filing Details
- Accession Number:
- 0001127430-17-000078
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-07 16:46:58
- Reporting Period:
- 2017-09-05
- Accepted Time:
- 2017-09-07 16:46:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202285 | Jr J Donald Hayden | 10 Finderne Avenue Building 10 Bridgewater NJ 08807 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-05 | 15,000 | $3.03 | 71,131 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-05 | 15,000 | $29.50 | 56,131 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-09-05 | 15,000 | $3.03 | 71,131 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-05 | 15,000 | $29.50 | 56,131 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-09-07 | 15,000 | $3.03 | 71,131 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-07 | 15,000 | $30.00 | 56,131 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-09-05 | 15,000 | $0.00 | 15,000 | $3.03 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-09-05 | 15,000 | $0.00 | 15,000 | $3.03 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-09-07 | 15,000 | $0.00 | 15,000 | $3.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 70,000 | 2021-12-21 | No | 4 | M | Direct | |
| 55,000 | 2021-12-21 | No | 4 | M | Direct | |
| 40,000 | 2021-12-21 | No | 4 | M | Direct |
Footnotes
- The exercise of stock options and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- Stock options granted on December 21, 2011 under the Company's 2000 Stock Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
Billionaire Hedge Funds
